AI stock discovery built on SEC filings with daily catalysts and plain-English summaries
Stage
Not given
Not given
Founded
Not given
Not given
Based in
Not given
ES
Pricing model
Freemium
Freemium
Pricing
Free tier available with no card required. Premium: $15/month billed monthly or $150/year (17% off). Premium+: $30/month billed monthly. All paid plans include a 14-day free trial.
Discovery tool: Free. API: Free (100 daily calls, attribution required); Builder €35.09/month or €350.90/year (EU prices incl. VAT); Pro €119.79/month or €1,197.90/year (EU prices incl. VAT).
Key features
Watchlist of up to 30 tickers (free) or 200 (premium) checked nightly for breakout patterns
Screener with 2,600+ stocks and crypto, 30 filters
Automatic support and resistance lines on charts
Edge Filter ranks breakouts by historical win rates and typical gains
Historical win rates and track record for each ticker
Daily Morning Brief setup recommendations
Breakout alerts for watchlist tickers
Suggested entry, stop and target for each pattern
API and MCP access for AI agents (Premium+)
See the company's own trading signals and account performance
Five-perspective scoring system (Fundamentals, Value, News flow, Momentum, Safety)
Discovery Gap measurement showing progress vs. market attention
Material 8-K event classification using language models
Monthly point-in-time snapshots never restated
Stock research API with JSON output
Company timeline of material events from filings
End-of-day market data integration
Filing alerts and company follow functionality
What makes it different
Ranks breakouts by historical win rate and typical gains instead of just showing patterns
Backtested strategy traded live with company's own money using transparent, fixed rules
Designed for swing traders who check once a day, not day traders watching screens
API integration for AI agents and custom systems
Transparent methodology: all five scoring perspectives shown with sources and evidence
Public record of all calls, including mistakes, never restated monthly
Research, not investment advice or recommendations